These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 32643902)

  • 41. CT Findings and Patterns of e-Cigarette or Vaping Product Use-Associated Lung Injury: A Multicenter Cohort of 160 Cases.
    Kligerman SJ; Kay FU; Raptis CA; Henry TS; Sechrist JW; Walker CM; Vargas D; Filev PD; Chung MS; Digumarthy SR; Ropp AM; Mohammed TL; Pope KW; Marquis KM; Chung JH; Kanne JP
    Chest; 2021 Oct; 160(4):1492-1511. PubMed ID: 33957099
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Update: Interim Guidance for Health Care Providers Evaluating and Caring for Patients with Suspected E-cigarette, or Vaping, Product Use Associated Lung Injury - United States, October 2019.
    Siegel DA; Jatlaoui TC; Koumans EH; Kiernan EA; Layer M; Cates JE; Kimball A; Weissman DN; Petersen EE; Reagan-Steiner S; Godfred-Cato S; Moulia D; Moritz E; Lehnert JD; Mitchko J; London J; Zaki SR; King BA; Jones CM; Patel A; Delman DM; Koppaka R; ;
    MMWR Morb Mortal Wkly Rep; 2019 Oct; 68(41):919-927. PubMed ID: 31633675
    [TBL] [Abstract][Full Text] [Related]  

  • 43. E-cigarette use related lung disease, review of clinical and imaging findings in 3 cases.
    Ansari-Gilani K; Petraszko AM; Teba CV; Reeves AR; Gupta A; Gupta A; Ramaiya NH; Gilkeson RC
    Heart Lung; 2020; 49(2):139-143. PubMed ID: 32008808
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Syndromic Surveillance for E-Cigarette, or Vaping, Product Use-Associated Lung Injury.
    Hartnett KP; Kite-Powell A; Patel MT; Haag BL; Sheppard MJ; Dias TP; King BA; Melstrom PC; Ritchey MD; Stein Z; Idaikkadar N; Vivolo-Kantor AM; Rose DA; Briss PA; Layden JE; Rodgers L; Adjemian J
    N Engl J Med; 2020 Feb; 382(8):766-772. PubMed ID: 31860794
    [No Abstract]   [Full Text] [Related]  

  • 45. ACMT Position Statement: Limiting Harms of Vaping and E-cigarette Use.
    Mazer-Amirshahi M; Garlich FM; Calello DP; Stolbach AI
    J Med Toxicol; 2021 Jan; 17(1):87-90. PubMed ID: 32601813
    [No Abstract]   [Full Text] [Related]  

  • 46. The E-cigarette or Vaping Product Use-Associated Lung Injury Epidemic: Pathogenesis, Management, and Future Directions: An Official American Thoracic Society Workshop Report.
    Rebuli ME; Rose JJ; Noël A; Croft DP; Benowitz NL; Cohen AH; Goniewicz ML; Larsen BT; Leigh N; McGraw MD; Melzer AC; Penn AL; Rahman I; Upson D; Crotty Alexander LE; Ewart G; Jaspers I; Jordt SE; Kligerman S; Loughlin CE; McConnell R; Neptune ER; Nguyen TB; Pinkerton KE; Witek TJ
    Ann Am Thorac Soc; 2023 Jan; 20(1):1-17. PubMed ID: 36584985
    [TBL] [Abstract][Full Text] [Related]  

  • 47. E-cigarette or vaping product use-associated lung injury.
    Ind PW
    Br J Hosp Med (Lond); 2020 Apr; 81(4):1-9. PubMed ID: 32339005
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clinical presentation, treatment, and short-term outcomes of lung injury associated with e-cigarettes or vaping: a prospective observational cohort study.
    Blagev DP; Harris D; Dunn AC; Guidry DW; Grissom CK; Lanspa MJ
    Lancet; 2019 Dec; 394(10214):2073-2083. PubMed ID: 31711629
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hypersensitivity Pneumonitis and Acute Respiratory Distress Syndrome From E-Cigarette Use.
    Sommerfeld CG; Weiner DJ; Nowalk A; Larkin A
    Pediatrics; 2018 Jun; 141(6):. PubMed ID: 29773665
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Lessons Learned From the E-cigarette, or Vaping, Product Use-Associated Lung Injury (EVALI) Outbreak Response, Minnesota, 2019-2020.
    Wiens T; Taylor J; Cole C; Saravia S; Peterson J; Lunda M; Margetta J; D'Heilly P; Holzbauer S; Lynfield R
    Public Health Rep; 2022; 137(6):1053-1060. PubMed ID: 34694926
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Adolescents' Awareness of E-Cigarette or Vaping Product Use-Associated Lung Injury (EVALI) and E-Cigarette Use Impact on Health.
    Cho EJ; Hill B; Lehew C; Rahmandar M; Fadavi S
    Pediatr Dent; 2023 Mar; 45(2):125-132. PubMed ID: 37106548
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Update: Characteristics of a Nationwide Outbreak of E-cigarette, or Vaping, Product Use-Associated Lung Injury - United States, August 2019-January 2020.
    Krishnasamy VP; Hallowell BD; Ko JY; Board A; Hartnett KP; Salvatore PP; Danielson M; Kite-Powell A; Twentyman E; Kim L; Cyrus A; Wallace M; Melstrom P; Haag B; King BA; Briss P; Jones CM; Pollack LA; Ellington S;
    MMWR Morb Mortal Wkly Rep; 2020 Jan; 69(3):90-94. PubMed ID: 31971931
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Diagnosis and Acute Management of E-Cigarette or Vaping Product Use-Associated Lung Injury in the Pediatric Population: A Systematic Review.
    Gonsalves CL; Zhu JW; Kam AJ
    J Pediatr; 2021 Jan; 228():260-270. PubMed ID: 32961169
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Demographics, Substance Use Behaviors, and Clinical Characteristics of Adolescents With e-Cigarette, or Vaping, Product Use-Associated Lung Injury (EVALI) in the United States in 2019.
    Adkins SH; Anderson KN; Goodman AB; Twentyman E; Danielson ML; Kimball A; Click ES; Ko JY; Evans ME; Weissman DN; Melstrom P; Kiernan E; Krishnasamy V; Rose DA; Jones CM; King BA; Ellington SR; Pollack LA; Wiltz JL;
    JAMA Pediatr; 2020 Jul; 174(7):e200756. PubMed ID: 32421164
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The rise of electronic nicotine delivery systems and the emergence of electronic-cigarette-driven disease.
    McAlinden KD; Eapen MS; Lu W; Sharma P; Sohal SS
    Am J Physiol Lung Cell Mol Physiol; 2020 Oct; 319(4):L585-L595. PubMed ID: 32726146
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinical, radiology, pathologic patterns and outcomes of vaping related pulmonary injury in a single institution; A case series.
    Kaous M; Xian J; Rongo D; McDonald M; Ocasionez D; Mathew R; Estrada-Y-Martin RM; Patel B; Cherian SV; Jani PP
    Respir Med; 2020 Nov; 173():106153. PubMed ID: 33017782
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Update: Product, Substance-Use, and Demographic Characteristics of Hospitalized Patients in a Nationwide Outbreak of E-cigarette, or Vaping, Product Use-Associated Lung Injury - United States, August 2019-January 2020.
    Ellington S; Salvatore PP; Ko J; Danielson M; Kim L; Cyrus A; Wallace M; Board A; Krishnasamy V; King BA; Rose D; Jones CM; Pollack LA;
    MMWR Morb Mortal Wkly Rep; 2020 Jan; 69(2):44-49. PubMed ID: 31945038
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Youth and young adult risk perceptions and behaviours in response to an outbreak of e-cigarette/vaping-associated lung injury (EVALI) in the USA.
    Kreslake JM; Diaz MC; Shinaba M; Vallone DM; Hair EC
    Tob Control; 2022 Jan; 31(1):88-97. PubMed ID: 33441461
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pediatric Chest Radiographic and CT Findings of Electronic Cigarette or Vaping Product Use-associated Lung Injury (EVALI).
    Artunduaga M; Rao D; Friedman J; Kwon JK; Pfeifer CM; Dettori A; Winant AJ; Lee EY
    Radiology; 2020 May; 295(2):430-438. PubMed ID: 32125258
    [TBL] [Abstract][Full Text] [Related]  

  • 60. E-cigarette or Vaping product use Associated Lung Injury (EVALI) in a 15 year old female patient - case report.
    Casamento Tumeo C; Schiavino A; Paglietti MG; Petreschi F; Ottavianelli A; Onofri A; Cherchi C; Tomà P; Cutrera R
    Ital J Pediatr; 2022 Jul; 48(1):119. PubMed ID: 35854320
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.